NO330251B1 - Farmasoytisk losning og fremgangsmater for fremstilling derav - Google Patents

Farmasoytisk losning og fremgangsmater for fremstilling derav Download PDF

Info

Publication number
NO330251B1
NO330251B1 NO20012793A NO20012793A NO330251B1 NO 330251 B1 NO330251 B1 NO 330251B1 NO 20012793 A NO20012793 A NO 20012793A NO 20012793 A NO20012793 A NO 20012793A NO 330251 B1 NO330251 B1 NO 330251B1
Authority
NO
Norway
Prior art keywords
pharmaceutically acceptable
acid
corresponding anion
pharmaceutical solution
solution according
Prior art date
Application number
NO20012793A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012793L (no
NO20012793D0 (no
Inventor
Gunilla Margareta Orn
Juha Kiesvaara
Kaija Af Ursin
Jukka Salmia
Heikki Niskanen
Pirjo Kortesuo
Mikko Kananen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20012793D0 publication Critical patent/NO20012793D0/no
Publication of NO20012793L publication Critical patent/NO20012793L/no
Publication of NO330251B1 publication Critical patent/NO330251B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Detergent Compositions (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20012793A 1998-12-17 2001-06-06 Farmasoytisk losning og fremgangsmater for fremstilling derav NO330251B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI982733A FI982733L (fi) 1998-12-17 1998-12-17 Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
PCT/FI1999/001046 WO2000035485A1 (en) 1998-12-17 1999-12-16 Soluble compositions of triphenylethylene antiestrogens

Publications (3)

Publication Number Publication Date
NO20012793D0 NO20012793D0 (no) 2001-06-06
NO20012793L NO20012793L (no) 2001-08-09
NO330251B1 true NO330251B1 (no) 2011-03-14

Family

ID=8553138

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012793A NO330251B1 (no) 1998-12-17 2001-06-06 Farmasoytisk losning og fremgangsmater for fremstilling derav

Country Status (13)

Country Link
US (2) US6632841B1 (de)
EP (1) EP1140196B1 (de)
JP (1) JP4523167B2 (de)
AT (1) ATE340591T1 (de)
AU (1) AU767714B2 (de)
CA (1) CA2355175C (de)
DE (1) DE69933388T2 (de)
ES (1) ES2272092T3 (de)
FI (1) FI982733L (de)
IL (2) IL143575A0 (de)
NO (1) NO330251B1 (de)
NZ (1) NZ512270A (de)
WO (1) WO2000035485A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI982733L (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
EP1832583A1 (de) * 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Neue Schwefelsäureadditionssalze aus Raloxifen und/oder Solvate daraus sowie pharmazeutische Zusammensetzungen damit
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
SI3202420T1 (sl) * 2008-12-11 2020-08-31 Besins Healthcare Luxembourg Sarl Transdermalni farmacevtski sestavki, ki obsegajo serm
WO2014043618A1 (en) * 2012-09-17 2014-03-20 Bind Therapeutics, Inc. Process for preparing therapeutic nanoparticles
RS60093B1 (sr) 2013-09-16 2020-05-29 Astrazeneca Ab Terapeutske polimerne nanočestice i postupci njihove pripreme i primene
EP3015453B1 (de) * 2014-10-28 2016-10-12 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Verfahren zur Herstellung von Clomiphen
EP3368506B1 (de) 2016-04-22 2023-09-06 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Verfahren zur herstellung von enclomiphencitrat mit nadelförmigem kristallhabitus

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE293263C (de)
FR2558373B1 (fr) 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
GB8604528D0 (en) * 1986-02-24 1986-04-03 Ici Plc Therapeutic agents
DK0396069T3 (da) 1989-05-05 1994-07-25 Asta Medica Ag Salte af azelastin med forbedret opløselighed
US5189212A (en) 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
GB9126209D0 (en) 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
DE4407742C1 (de) 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US5441986A (en) 1994-07-19 1995-08-15 Pfizer Inc. Estrogen agonists as remedies for prostate and cardiovascular diseases
BR9713176A (pt) * 1996-08-28 2000-02-08 Lilly Co Eli Benzotiofenos amorfos,métodos de preparação e métodos de uso
CA2219377A1 (en) * 1996-10-30 1998-04-30 Eli Lilly And Company Improvements in or relating to the prophylaxis of breast cancer
US6114395A (en) 1996-11-15 2000-09-05 Pfizer Inc. Method of treating atherosclerosis
DK0893121T3 (da) 1997-06-27 2002-06-17 Akzo Nobel Nv Flydende oral medicinopløsning
EP1028724A1 (de) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermale verabreichung von 3,4-diarylchromane
FI109332B (fi) * 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733L (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia

Also Published As

Publication number Publication date
AU767714B2 (en) 2003-11-20
FI982733A7 (fi) 2000-06-18
US20030181530A1 (en) 2003-09-25
FI982733A0 (fi) 1998-12-17
CA2355175A1 (en) 2000-06-22
ATE340591T1 (de) 2006-10-15
EP1140196B1 (de) 2006-09-27
AU1985500A (en) 2000-07-03
DE69933388T2 (de) 2007-08-23
US6887888B2 (en) 2005-05-03
IL143575A (en) 2006-12-10
NZ512270A (en) 2003-01-31
EP1140196A1 (de) 2001-10-10
NO20012793L (no) 2001-08-09
FI982733L (fi) 2000-06-18
US6632841B1 (en) 2003-10-14
NO20012793D0 (no) 2001-06-06
WO2000035485A1 (en) 2000-06-22
ES2272092T3 (es) 2007-04-16
JP2002532437A (ja) 2002-10-02
JP4523167B2 (ja) 2010-08-11
CA2355175C (en) 2008-07-15
DE69933388D1 (de) 2006-11-09
IL143575A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
NO330251B1 (no) Farmasoytisk losning og fremgangsmater for fremstilling derav
CN109689038B (zh) 含有5-氨基乙酰丙酸类的水性制剂
JP5108517B2 (ja) 治療活性剤、クエン酸または共役塩基、および二酸化塩素を含む安定化された組成物
JP2014508146A (ja) 抗真菌組成物
RU2008146217A (ru) Фармацевтическая композиция, содержащая производное таксана, которая предназначена для приготовления инфузионного раствора, способ его приготовления и использование
JP3659801B2 (ja) トラニラスト水溶液製剤
EP2656856A2 (de) Tablettenformulierung mit Levodopa, Carbidopa, Entacapon mit verlängerter Freisetzung
EP2804597A1 (de) Wässrige paracetamolzusammensetzung zur injektion
JP2004238346A (ja) トラニラストの安定な水溶液製剤
AU2016209917B2 (en) Galenic formulation comprising a topical drug
ES2220138T3 (es) Composiciones solubles de toremifeno.
JP7116434B2 (ja) メマンチン含有経皮吸収型液剤
JPH0327544B2 (de)
AU2024318152A1 (en) Topical agent for onychomycosis
HK40000663B (zh) 含有5-氨基乙酰丙酸类的水性制剂
CN119506016A (zh) 一种复配型洗涤用防腐剂及其制备方法和应用
WO2007046318A1 (ja) インドメタシンを含有する外用液剤
TW201601717A (zh) 含有經安定化之２－胺基－３－（４－溴苯甲醯基）苯基醋酸之水性組成物
HK40000663A (en) Aqueous formulation containing 5-aminolevulinic acid or the like
EP1902705A1 (de) Injizierbare pharmazeutische Lösungen mit Nimesulid
CN101969936A (zh) 一种制备通过外用贴剂给药的、具有消炎镇痛活性的药物组合物的方法,以及用该方法所获得的组合物

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees